The Parkinson Progression Marker Initiative (PPMI)Kenneth Marek, Marne Baca, Danna Jennings et al.|Progress in Neurobiology|2011Cited by 1.9k
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 studyOsama Sabri, James B. Leverenz, Bernardino Ghetti et al.|Alzheimer s & Dementia|2015Cited by 605
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsDavid G. Standaert, Chelsea Caspell‐Garcia, Christopher S. Coffey et al.|Neurology|2017Cited by 152
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s diseaseSandra Sanabria Bohórquez, Robby M. Weimer, Jan Mařı́k et al.|European Journal of Nuclear Medicine and Molecular Imaging|2019Cited by 130
Kinetic Modeling of the Tau PET Tracer <sup>18</sup>F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease SubjectsOlivier Barret, Danna Jennings, David Alagille et al.|Journal of Nuclear Medicine|2016Cited by 77